Respondents with Zero Trust models leveraging Next-Gen Access report reduced overall risk and lower security-related costs
Centrify, a leading provider of Zero Trust Security through the power of Next-Gen Access, today announced results of a commissioned study conducted by Forrester Consulting on behalf of Centrify, which finds that organisations powering Zero Trust Security with Next-Gen Access solutions reported twice the confidence to accelerate new business models and customer experiences.
The study of 311 IT decision-makers in North America and the UK finds that 67 per cent of all enterprise resources are exposed to access-related risk, and that a Zero Trust Security approach is the best strategy to control access to enterprise resources.
The study revealed that Next-Gen Access is the engine that powers Zero Trust Security, stating that, “NGA technologies enable the layers necessary for a successful Zero Trust strategy.” Organisations using Next-Gen Access solutions – including Identity-as-a-Service (IDaaS), Enterprise Mobility Management (EMM), and Privileged Access Management (PAM) – also reported topline benefits including being 66 per cent more confident in adopting mobile work models, and 44 per cent more confident in securing DevOps environments. Those same respondents reported bottom line benefits of mitigating overall risk by 37 per cent and reducing security costs by 31 per cent.
According to Forrester, 58 per cent of global enterprises have experienced a breach in the past 12 months. According to the study, “Security leaders are urgently scrambling to defend every entry point, but traditional approaches to security, based on keeping out the ‘bad guys,’ while letting in the good guys, have proven ineffective.” In response, many security leaders are turning to Zero Trust approaches that remove trust from the equation completely, shunning the traditional “trust but verify” approach and replacing it with a “never trust, always verify” mandate.
“The dissolving network perimeter is causing a complete rethink in how we approach security, taking into account a new enterprise reality defined by the cloud, mobility, and increasing demands for agility,” said Tom Kemp, CEO of Centrify. “This study reveals that two-thirds of enterprise resources are exposed to access-related risk, largely because organisations are approaching security in a way that no longer works and with solutions that are ineffective. Zero Trust Security, powered by Next-Gen Access, reduces risk and costs, while ushering in a new era in customer experiences and business models.”
“Zero Trust is the best strategy to control access,” the study states. “Successful access control is a key pillar in Forrester’s Zero Trust model for securing today’s enterprises. A Zero Trust strategy, as the name implies, rests on security leaders not making any trust assumptions throughout their security architecture.”
To enforce user access, a Zero Trust strategy requires that an organisation’s security must have the capability to:
- Verify the identity of every user through a combination of identity governance, single sign-on, and multifactor authentication (MFA) to eliminate the risk of credential compromise.
- Validate every device with mobile device management to enforce secure policy, with local administrator privilege management to eliminate local admin compromise, and with device identity management to ensure that only trusted devices are allowed to access resources.
- Limit access and privilege using privileged access management to ensure a user has just enough access and only the necessary privileges to perform their job during any given time.
- Continually learn and adapt using behavior-based analytics and privileged access auditing/monitoring to automatically improve and personalise access policies.
Centrify’s Next-Gen Access delivers a unified, industry-recognised solution that uniquely converges IDaaS, EMM and PAM to address these four pillars of Zero Trust Security. This seamless integration secures access across applications, endpoints and infrastructure for all users, without sacrificing best-of-breed features.
Car sector seeks more UK government support as output tumbles
LONDON (Reuters) – British finance minister Rishi Sunak should use next week’s budget statement to help boost the car industry’s competitiveness, a trade industry body said on Friday, as production tumbled to its lowest January level since 2009.
Sunak is due to detail how he will further support the economy amid COVID-19 restrictions on March 3.
The Society of Motor Manufacturers and Traders (SMMT) said the furlough scheme that protects jobs should be extended, more support for training was needed and manufacturing investment should be encouraged through reform of the business rates tax.
“Next week’s budget is the chancellor’s (finance minister) opportunity to boost the industry by introducing measures that will support competitiveness, jobs and livelihoods,” SMMT Chief Executive Mike Hawes said.
“We need to secure our medium to long-term future by creating the conditions that will attract battery gigafactory investment and transform the supply chain.”
Output in January fell by 27% year-on-year to 86,052 vehicles, hit by factors including dealership closures during a latest COVID-19 lockdown, international supply chain problems and the change in trading terms with the European Union.
(Reporting by Costas Pitas; Editing by William Schomberg)
Exclusive: Portugal sees green hydrogen output by end-2022, $12 billion in investment lined up
By Sergio Goncalves
LISBON (Reuters) – Portugal will start producing green hydrogen by the end of 2022 and already has private investment worth around 10 billion euros ($12 billion) lined up for eight projects that are expected to move forward, Environment Minister Joao Matos Fernandes said.
He told Reuters in a telephone interview there were also several “pre-contracts for the purchase and assembly of electrolysers” to produce the zero-carbon fuel made by electrolysis out of water using renewable wind and solar energy.
Such hydrogen is more expensive to extract than the heavily polluting conventional method of using heat and chemical reactions to release hydrogen from coal or natural gas, known as brown and grey hydrogen respectively.
Hydrogen is now mostly used in the oil refining industry and to produce ammonia fertilisers, but sectors such as steelmaking, transportation and chemicals are beginning to develop large-scale hydrogen applications to gradually replace fossil fuels as countries try to reduce pollution.
The European Commission has mapped out a plan to scale up green hydrogen projects across polluting sectors to meet a net zero emissions goal by 2050 and become a leader in a market analysts expect to be worth $1.2 trillion by that date.
“By the end of 2022, there will certainly be green hydrogen production in Portugal,” Matos Fernandes said. “Green hydrogen will, over time, allow Portugal to completely change its paradigm and become an energy exporting country.”
He said seven groups had submitted applications under Europe’s IPCEI scheme for common-interest projects to make part of a planned export-oriented “hydrogen cluster” near the port of Sines, from where hydrogen could be shipped to Rotterdam. Total investment there is estimated at some 7 billion euros.
A consortium including Portugal’s main utility EDP, oil company Galp, world’s largest wind turbine maker Vestas, among others, is behind one of the projects.
In Estarreja in north Portugal, local firm Bondalti Chemicals aims to invest 2.4 billion euros in a hydrogen plant.
Altogether, these envisage an installed capacity of over 1,000 megawatts (MW).
Matos Fernandes said Portugal was also negotiating with Spain the construction of a pipeline for renewable gases, including hydrogen, from Sines to France, crossing Spain.
Spain and Portugal also want to develop an ambitious cross-border lithium project taking advantage of the geographical proximity of their lithium deposits and aiming to cover the entire value chain from mining to refining, cell and battery manufacturing to battery recycling, he said.
Portugal is already a large producer of low-grade lithium mainly for the ceramics industry, but is preparing to make higher-grade metal used in electric car batteries.
A much-awaited licensing tender for lithium-bearing areas that has been delayed by the COVID-19 pandemic should take place by the year-end, Matos Fernandes said.
He promised the tender would address environmental concerns by local communities and there would be no lithium mining “at any cost”.
The minister also said Portugal would use its six-month presidency of the Council of the European Union to finalise a landmark law that would make the bloc’s climate targets irreversible and speed up emissions cuts this decade, expecting it to be approved in the first half of 2021.
(Reporting by Sergio Goncalves; Editing by Andrei Khalip and David Evans)
Under fire in EU, AstraZeneca CEO says ‘hopefully’ will meet vaccine supply goals
BRUSSELS (Reuters) – AstraZeneca boss Pascal Soriot said on Thursday he hoped to meet the European Union’s expectations on the number of COVID-19 vaccines the company can deliver to the bloc in the second quarter, after big cuts in the first three months of the year.
The Anglo-Swedish drugmaker has been under fire in the EU for its delayed supplies of shots to the 27-nation bloc, which ordered 300 million doses by the end of June.
“We are working 24/7 to improve delivery and hopefully catch up to the expectations for Q2,” Soriot told EU lawmakers in a public hearing.
Under its contract with the EU, the company has committed to delivering 180 million doses in the second quarter.
Soriot did not mention the 180 million target, but said he was confident the company will be able to increase production in the second quarter using factories outside the EU that had no production problems, including in the United States.
He confirmed the company was trying to get 40 million doses of the COVID-19 vaccine to the EU by the end of March, which is less than half the amount it promised for the quarter in its contract.
The EU, which has fallen far behind the United States and former member Britain in vaccinating its public, has repeatedly urged the firm to deliver more.
Lower-than-expected yields – the amount of vaccine that can be produced from base ingredients – at its factories hurt output in the first three months.
Asked about supplies to Britain, which relies on the same factories used by the EU, Soriot said the former EU member with a population of around 66 million was smaller, and noted that most doses produced in the EU were used to serve the EU which has a population of about 450 million.
Executives from rival drugmakers that have developed or are testing COVID-19 vaccines, including Moderna Inc and CureVac NV were also part of the panel.
But most questions were directed at Soriot amid anger that the company has failed to deliver promised vaccine quantities to the bloc on schedule.
Moderna Chief Executive Officer Stephane Bancel said the company has experienced fluctuations as the U.S. biotech group ramps up output of its COVID-19 vaccine.
He said usually a company would stockpile product ahead of a launch, but it is shipping every dose it makes, leaving it without any spare inventory.
His comments came a day after the company increased its output target for this year and 2022 as it invests in additional manufacturing capacity.
(Reporting by Josephine Mason in London and Francesco Guarascio in Brussels; Editing by Susan Fenton, Bill Berkrot and Keith Weir)
Radiation Toxicity Treatment Market is Expected to Register Highest CAGR of 6% During the Forecast Period 2019 – 2029
The rise in installation of radiation therapy machines to treat a wide range of cancers further uplifts the probability of...
Sales of Medical X-Ray Detectors on Upswing, Manufacturers to Prioritize Portable and Digital Imaging and Scanning Devices
Medical X-ray detectors market revenue was valued to be US$ 1 Bn in 2019, as per Future Market Insights (FMI)’s latest...
Demand for Cardiac Assist Devices on Upswing, Integration of Internet of Things (IoT) Underway, Finds FMI
The global market for cardiac assist devices is expected to reach a remarkable net worth of US$ 37 Bn by the end...
FMI’s Study Highlights Accelerating Sales of 3D Printed Medical Devices at Double-digit CAGR
As the medical industry continues to leverage the power of additive software and hardware in optimizing the design of prosthetics...
Actinic Keratosis Treatment Set to Move Towards Combination Therapy, North America to Capture Major Share, Says FMI
The global actinic keratosis treatment market is projected to reach US$ 8.5 Bn by the end of 2029, growing at a CAGR...